Lopid, Gemfibrozil Newswire

Comprehensive Real-Time News Feed for Lopid, Gemfibrozil (generic).

Results 1 - 10 of 10 in Lopid, Gemfibrozil (generic)

  1. Abstract 201: Gemfibrozil In Combination With Statin Is Associated...Read the original story

    Jun 2, 2014 | Circulation

    Objective: Statins and gemfibrozil as individual monotherapy have shown to reduce major cardiovascular events with statins alone reducing all cause mortality.


  2. Statins and OATP InteractionsRead the original story

    Jun 16, 2014 | Pharmacy Times

    In the past, this column has described drug interactions that may occur with statins.1 The majority of these interactions have been based on precipitant drugs inhibiting the metabolism of the statin.


  3. Arsonists and Firefighters: The Perpetual Inflammatory Civil War for Survival [Editorials]Read the original story

    Jun 9, 2014 | Circulation

    From the Cardiology Section, VA Medical Center and the Department of Medicine and the Cardiovascular Research Institute, University of California, San Francisco, CA.


  4. Largest Study Compares Cholesterol Treatment In HIV Patients And Patients Without HIVRead the original story w/Photo

    Mar 2, 2009 | Science Daily

    A new study that is the largest to date has found that cholesterol medications can work well among certain HIV patients at risk for cardiovascular disease.


  5. Gemfibrozil TabletsRead the original story

    Sep 1, 2010 | ASHP

    Blu has gemfibrozil available in 60 count , 180 count , and 500 count sizes. Pfizer has available Lopid 600 mg tablets in 60 and 500 count presentations.


  6. Physicians should not be expected to blindly follow guidelinesRead the original story

    Apr 15, 2014 | Kevin, M.D.

    Barron Lerner thinks he understands doctor's motives. In his recent article in the Atlantic he laments that physicians act on tradition and emotion over adopting new science.


  7. Tribute Pharmaceuticals Appoints JSB-Partners to Lead Partnership...Read the original story

    Mar 12, 2014 | Hispanic Business

    The Investigational New Drug Application for Bezalip SR was cleared by the . "We are delighted to have the support of JSB as we continue to work towards the partnering and ultimately the regulatory approval of Bezalip SR in the U.S.," said , President and CEO of Tribute.


  8. Liver Drug Race: Intercept Pharma Vs. RivalsRead the original story

    Jan 26, 2014 | Seeking Alpha

    In mid-January a little-known biotech Intercept Pharmaceuticals' market capitalization leaped from $1.4 billion to $8.6 billion in a matter of days and the stock price touched briefly a high of $497.00.


  9. Mylan Inc. Launches Generic Prandin TabletsRead the original story

    Jan 24, 2014 | BioSpace

    This product is the generic version of Novo Nordisk's PrandinA , which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.


  10. Mylan Launches Generic Prandin TabletsRead the original story

    Jan 23, 2014 | Freshnews

    Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg.